Company Data
NextCure Inc.
Ticker
NXTC
Current Price
$0.722901 -3.74%
Market Cap
$20.2M
Price Target
Refer to Report
Volume
31.2K
52wk Range
$0.6603 - $2.57
Overview
NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. It is focused on understanding biological pathways, the interactions of cells and the role each interaction plays in an immune response. The company’s product candidate, NC318, is an immunomedicine against an immunomodulatory receptor called Siglec-15, or S15.